Insider Transactions in Q3 2024 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 17
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-42.21%
|
$1,155,000
$77.7 P/Share
|
Sep 17
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+40.63%
|
$120,000
$8.66 P/Share
|
Sep 10
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$111,000
$74.41 P/Share
|
Sep 10
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
Sep 05
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,421
-26.94%
|
$239,470
$70.02 P/Share
|
Sep 05
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,421
+21.22%
|
$51,315
$15.0 P/Share
|
Sep 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
27,451
-23.18%
|
$1,866,668
$68.09 P/Share
|
Sep 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
27,451
+27.11%
|
$274,510
$10.64 P/Share
|
Aug 26
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,684
-41.48%
|
$1,517,880
$70.97 P/Share
|
Aug 26
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,684
+41.19%
|
$325,260
$15.0 P/Share
|
Aug 20
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$97,500
$65.88 P/Share
|
Aug 20
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
Aug 16
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,450
-37.0%
|
$354,250
$65.05 P/Share
|
Aug 16
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,450
+27.01%
|
$32,700
$6.28 P/Share
|
Aug 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-36.56%
|
$1,200,000
$60.76 P/Share
|
Aug 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.06%
|
$200,000
$10.64 P/Share
|
Jul 30
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-93.33%
|
$93,000
$62.38 P/Share
|
Jul 30
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
Jul 16
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,901
-54.02%
|
$708,565
$65.3 P/Share
|
Jul 16
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,901
+35.07%
|
$65,406
$6.28 P/Share
|
Jul 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,780
-16.1%
|
$106,800
$60.21 P/Share
|
Jul 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,780
+13.87%
|
$10,680
$6.28 P/Share
|
Jul 11
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,671
-28.35%
|
$220,260
$60.01 P/Share
|
Jul 11
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,671
+22.09%
|
$22,026
$6.28 P/Share
|
Jul 09
2024
|
Kavita Patel |
SELL
Open market or private sale
|
Direct |
1,500
-78.4%
|
$84,000
$56.69 P/Share
|
Jul 09
2024
|
Kavita Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$9,000
$6.66 P/Share
|
Jul 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-40.94%
|
$1,100,000
$55.73 P/Share
|
Jul 01
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.41%
|
$200,000
$10.64 P/Share
|